| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d47a0fd25ed17097d6ca7c1450ca882 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
2011-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a0e8da61c823b51581e7c18122702d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3eaf797a4db9ccd748e29f85454be1f |
| publicationDate |
2012-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101156054-B1 |
| titleOfInvention |
Sustained-release pharmaceutical composition containing stable eferison |
| abstract |
The present invention relates to a stable ephrison-containing sustained-release pharmaceutical composition, which will be described in more detail, by including a specific type of acidifying agent such as carbomer, citric acid and the like to be formulated to a pH of 5.6 or less, to ensure long-term storage stability of the preparation and in the gastrointestinal tract. The drug of the present invention requires fast-acting and sustained release by controlling the specific delayed release agent, as well as suppressing the decomposition of the main component even in extreme environments such as pH change due to the nature of the sustained-release preparation that requires long-term retention in It is possible to implement a sustained release formulation of the double-release properties that can make good use of the properties of. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013105819-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101799321-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102444073-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014157851-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101832842-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101497354-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014157852-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210088285-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200117138-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101760278-B1 |
| priorityDate |
2011-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |